Patents by Inventor Pierre FERRÉ

Pierre FERRÉ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS, ANTI-TIGIT ANTIBODIES, AND ANTI-PD-1 ANTIBODIES
    Publication number: 20230365680
    Abstract: The present invention is directed to combination treatments with anti-PVRIG antibodies, anti-TIGIT antibodies, and anti-PD-1 antibodies, in particular nivolumab, using stable liquid pharmaceutical formulations thereof.
    Type: Application
    Filed: September 30, 2021
    Publication date: November 16, 2023
    Inventors: Adeboye Henry ADEWOYE, MD, Inbal BARBIRO, Ilan VAKNIN, Eran OPHIR, Pierre FERRE
  • RECEPTOR FOR VISTA
    Publication number: 20230243836
    Abstract: The present disclosure provides methods for modulating (e.g., preventing, inhibiting, blocking) the interaction of PSGL-1 and VISTA with agents (e.g., antibodies) that bind to PSGL-1 and/or VISTA.
    Type: Application
    Filed: July 22, 2019
    Publication date: August 3, 2023
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Pierre FERRÉ, Francisco CRUZALEGUI, Noureddine LOUKILI, Olivier DELFOUR, Edward Thein Htun VAN DER HORST
  • ANTI-VSIG4 ANTIBODY OR ANTIGEN BINDING FRAGMENT AND USES THEREOF
    Publication number: 20220306736
    Abstract: New anti-VSIG4 (V-set Ig domain-containing 4) antibodies or an antigen-binding fragments are disclosed. Uses of these antibodies, including methods of treatment, are also provided.
    Type: Application
    Filed: September 4, 2020
    Publication date: September 29, 2022
    Applicants: Y-BIOLOGICS INC., PIERRE FABRE MEDICAMENT
    Inventors: Noureddine LOUKILI, Florence BAYCHELIER-TINE, Pierre FERRE, Young Woo PARK, Bum-Chan PARK, Jae Eun PARK, Hyun Mi LEE, Soo Young KIM
  • VINFLUNINE AND PD1 AND/OR PDL1 INHIBITOR AS PHARMACEUTICAL COMBINATION
    Publication number: 20190307741
    Abstract: The present invention relates to a pharmaceutical combination comprising: (a) vinflunine or a pharmaceutically acceptable salt thereof, and (b) at least one PD1-inhibitor and/or at least one PD-L1-inhibitor or pharmaceutically acceptable salt thereof. Such a pharmaceutical combination is useful as a drug, notably in the treatment of a proliferative disease, such as cancer.
    Type: Application
    Filed: July 6, 2017
    Publication date: October 10, 2019
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Anna KRUCZYNSKI, Isabelle VANDENBERGHE, Pierre FERRE